Article | September 1, 2023

Biopharma Manufacturing For Advanced Therapies: A Panel Discussion

Source: Cytiva

While new biologic modalities hold great potential as powerful therapeutic tools, they also pose several manufacturing and development hurdles that the biomanufacturing industry is actively working to overcome. Companies are tasked with improving and expanding upon current process development models, all the while managing limitations in capacity and supply chain constraints.

In a Financial Times panel discussion organized in partnership with Cytiva, experts in this fast-growing field discussed ways to improve biomanufacturing processes to help ensure the next generation of advanced therapies is both accessible and affordable to patients. Explore highlights from the panel discussion on the key challenges of scalability, automation, and flexibility.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online